Celldex (CLDX) Tops Q1 EPS by 15c

Celldex (NASDAQ: CLDX) reported Q1 EPS of ($0.56), $0.15 better than the analyst estimate of ($0.71). Revenue for the quarter came in at $156 thousand versus the consensus estimate of $732.6 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Evercore ISI Reiterates Underperform Rating on Lennar (LEN)